New Treatment Option Approved For Lennox-Gastaut Syndrome
The U.S. FDA has approved Topamax (topiramate) tablets and sprinkle capsules as an adjunctive (add-on) treatment for adults and children (age 2-16) suffering from seizures associated with Lennox-Gastaut Syndrome (LGS) is one of the most severe forms of epilepsy. Individuals who suffer from this illness experience dozens of seizures a day, many of which are Read more about New Treatment Option Approved For Lennox-Gastaut Syndrome[…]